BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 20827160)

  • 1. Is Kaposi's sarcoma occurring at higher CD4 cell counts over the course of the HIV epidemic?
    Crum-Cianflone NF; Hullsiek KH; Ganesan A; Weintrob A; Okulicz JF; Agan BK;
    AIDS; 2010 Nov; 24(18):2881-3. PubMed ID: 20827160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroreactivity to Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent nuclear antigen in AIDS-associated Kaposi's sarcoma patients depends on CD4+ T-cell count.
    de Souza VA; Pierrotti LC; Sumita LM; Freire WS; Segurado AA; Pannuti CS
    J Med Virol; 2007 Oct; 79(10):1562-8. PubMed ID: 17705173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for Kaposi's sarcoma in human immunodeficiency virus patients after initiation of antiretroviral therapy: A nested case-control study in Kenya.
    Lupia R; Wabuyia PB; Otiato P; Fang CT; Tsai FJ
    J Microbiol Immunol Infect; 2017 Dec; 50(6):781-788. PubMed ID: 26712092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
    Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
    AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kaposi's sarcoma in HIV-infected women and men in Nigeria.
    Ibekwe PU; Ogunbiyi OA; Ogun GO; George OA
    AIDS Patient Care STDS; 2011 Nov; 25(11):635-7. PubMed ID: 21967494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kaposi's sarcoma in HIV infection: impact on opportunistic infections and survival.
    Brodt HR; Kamps BS; Helm EB; Schöfer H; Mitrou P
    AIDS; 1998 Aug; 12(12):1475-81. PubMed ID: 9727568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors influencing antibody responses to Kaposi's sarcoma-associated herpesvirus latent and lytic antigens in patients under antiretroviral therapy.
    Guadalupe M; Pollock BH; Westbrook S; Redding S; Bullock D; Anstead G; Agan BK; Marconi VC; Barbieri S; Sankar V; Rebeles J; Flahive Y; Schoolfield J; Wang L; Lei X; Dow D; Yeh CK; Dang H; Infante AJ; Gao SJ
    J Acquir Immune Defic Syndr; 2011 Jan; 56(1):83-90. PubMed ID: 21084997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to: a retrospective analysis of AIDS-associated Kaposi's sarcoma in patients with undetectable HIV viral loads and CD4 counts greater than 300 cells/mm(3).
    Maurer T; Leslie K; Unemori P
    J Int Assoc Physicians AIDS Care (Chic); 2010; 9(2):73. PubMed ID: 20484734
    [No Abstract]   [Full Text] [Related]  

  • 9. Virologic and immunologic parameters that predict clinical response of AIDS-associated Kaposi's sarcoma to highly active antiretroviral therapy.
    Pellet C; Chevret S; Blum L; Gauvillé C; Hurault M; Blanchard G; Agbalika F; Lascoux C; Ponscarme D; Morel P; Calvo F; Lebbé C
    J Invest Dermatol; 2001 Oct; 117(4):858-63. PubMed ID: 11676823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-associated Kaposi's sarcoma with a high CD4 count and a low viral load.
    Maurer T; Ponte M; Leslie K
    N Engl J Med; 2007 Sep; 357(13):1352-3. PubMed ID: 17898112
    [No Abstract]   [Full Text] [Related]  

  • 11. Kaposi's sarcoma-associated immune reconstitution following highly active antiretroviral treatment initiation.
    Chan DJ
    Int J STD AIDS; 2006 Jan; 17(1):72. PubMed ID: 16409689
    [No Abstract]   [Full Text] [Related]  

  • 12. Changing patterns of Kaposi's sarcoma in Danish acquired immunodeficiency syndrome patients with complete follow-up. The Danish Study Group for HIV Infection (DASHI).
    Lundgren JD; Melbye M; Pedersen C; Rosenberg PS; Gerstoft J
    Am J Epidemiol; 1995 Apr; 141(7):652-8. PubMed ID: 7702040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and biological impact of antiretroviral therapy with protease inhibitors on HIV-related Kaposi's sarcoma.
    Lebbé C; Blum L; Pellet C; Blanchard G; Vérola O; Morel P; Danne O; Calvo F
    AIDS; 1998 May; 12(7):F45-9. PubMed ID: 9619797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for Kaposi's sarcoma in HIV-positive subjects in Uganda.
    Ziegler JL; Newton R; Katongole-Mbidde E; Mbulataiye S; De Cock K; Wabinga H; Mugerwa J; Katabira E; Jaffe H; Parkin DM; Reeves G; Weiss R; Beral V
    AIDS; 1997 Nov; 11(13):1619-26. PubMed ID: 9365767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of HIV-1-associated Kaposi's sarcoma among women and men in South Africa.
    Mosam A; Hurkchand HP; Cassol E; Page T; Cassol S; Bodasing U; Aboobaker J; Dawood H; Friedland GH; Coovadia HM
    Int J STD AIDS; 2008 Jun; 19(6):400-5. PubMed ID: 18595878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular immune responses and disease control in acute AIDS-associated Kaposi's sarcoma.
    Bihl F; Berger C; Chisholm JV; Henry LM; Bertisch B; Trojan A; Nadal D; Speck RF; Flepp M; Brander C; Mueller NJ;
    AIDS; 2009 Sep; 23(14):1918-22. PubMed ID: 19609199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in the pattern of Kaposi's sarcoma at Ocean Road Cancer Institute in Tanzania (2006-2011).
    Koski L; Ngoma T; Mwaiselage J; Le L; Soliman AS
    Int J STD AIDS; 2015 Jun; 26(7):470-8. PubMed ID: 25080290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kaposi sarcoma herpes virus antibody response and viremia following highly active antiretroviral therapy in the Swiss HIV Cohort study.
    Sullivan SG; Hirsch HH; Franceschi S; Steffen I; Amari EB; Mueller NJ; Magouras I; Biggar RJ; Rickenbach M; Clifford GM;
    AIDS; 2010 Sep; 24(14):2245-52. PubMed ID: 20543658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinico-epidemiologic characteristics and patterns of care in Kaposi's sarcoma: Data from a single-institution series.
    Hwang A; Iskandar AS; Kerr WT; Farrell S; Plaxe SC; Dasanu CA
    J Oncol Pharm Pract; 2019 Oct; 25(7):1719-1721. PubMed ID: 30940048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A retrospective analysis of AIDS-associated Kaposi's sarcoma in patients with undetectable HIV viral loads and CD4 counts greater than 300 cells/mm(3).
    Mani D; Neil N; Israel R; Aboulafia DM
    J Int Assoc Physicians AIDS Care (Chic); 2009; 8(5):279-85. PubMed ID: 19721098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.